Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001493152-23-016483
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$785.08K | -$963.39K | -$1.78M | -$540.50K |
| EPS Diluted | -$0.01 | — | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end
